Lineage Determination of CD20– B-Cell Neoplasms

Peiguo Chu(City of Hope), Lawrence M. Weiss(NeoGenomics (United States)), Sofia Loera(City Of Hope National Medical Center), Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region)
American Journal of Clinical Pathology
October 1, 2006
10.1309/3wg32yramq7rb9d4
Cited by 66

Related Papers

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.
|Journal of Biological Chemistry|1993|375
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
|Leukemia|2012|362